Cargando…
Prognosis of Pancreatic Cancer Based on Resectability: A Single Center Experience
SIMPLE SUMMARY: Conversion surgery has been increasingly performed for initially unresectable advanced pancreatic ductal adenocarcinoma (PDAC). Patients with PDAC were classified into three groups: resectable (R), borderline resectable (BR), and unresectable (UR). In total, 211 patients (R, 118; BR,...
Autores principales: | Einama, Takahiro, Takihata, Yasuhiro, Aosasa, Suefumi, Konno, Fukumi, Kobayashi, Kazuki, Yonamine, Naoto, Fujinuma, Ibuki, Tsunenari, Takazumi, Nakazawa, Akiko, Shinto, Eiji, Ueno, Hideki, Kishi, Yoji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954753/ https://www.ncbi.nlm.nih.gov/pubmed/36831444 http://dx.doi.org/10.3390/cancers15041101 |
Ejemplares similares
-
Clinical Impact of Dual Time Point (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging in Pancreatic Cancer
por: Einama, Takahiro, et al.
Publicado: (2022) -
Therapeutic efficacy of dose-reduced adjuvant chemotherapy with S-1 in patients with pancreatic cancer: a retrospective study
por: Kobayashi, Kazuki, et al.
Publicado: (2022) -
Different role of MSLN and CA125 co-expression as a prognostic predictor between perihilar and distal bile duct carcinoma
por: Takihata, Yasuhiro, et al.
Publicado: (2021) -
Co-expression of mesothelin and CA125/MUC16 is a prognostic factor for breast cancer, especially in luminal-type breast cancer patients
por: Einama, Takahiro, et al.
Publicado: (2021) -
Recurrent cholangiocarcinoma with long-term survival by multimodal treatment: A case report
por: Sota, Yuki, et al.
Publicado: (2021)